Mission

Broad applications of the NRAMRB platform are anticipated to provide several benefits over the course of time, including, though not limited to, the following:

- Using drug resistance isolates as a resource for the verification and validation of novel diagnostic tests

- Use of isolates in studies for validation of detection of phenotypic susceptibility or molecular markers of resistance

- Aiding in the process of development of newer drugs and therapeutic modalities

- Vaccine development against clinically significant pathogens

- Development and validation of bioinformatics-based tools to develop algorithms to identify and/or predict putative antimicrobial resistance genes in clinical isolates

- Exploring the use of emerging technology, artificial intelligence, and machine learning to shorten the diagnostic lag period for infectious diseases